Intelligent Blood Treatment System with Synergistic Combinations

Publication ID: 24-11857711_0003_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Blood Treatment System with Synergistic Combinations,” Published Technical Disclosure No. 24-11857711_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857711_0003_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,711.

Summary of the Inventive Concept

The present inventive concept integrates a blood treatment apparatus with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful system, enabling personalized treatment recommendations, real-time feedback, and secure data management.

Background and Problem Solved

The original patent disclosed a method for setting a control device or a closed-loop control device of a blood treatment apparatus. However, this method had limitations in terms of data analysis, security, and personalized treatment. The new inventive concept addresses these limitations by incorporating synergistic combinations of technologies to enhance the blood treatment apparatus.

Detailed Description of the Inventive Concept

The new inventive concept comprises a blood treatment apparatus integrated with an AI-powered predictive analytics module, a blockchain-based decentralized data storage system, an IoT-enabled sensor network, and a machine learning-based decision support system. The AI module analyzes treatment data and provides personalized treatment recommendations to a user. The blockchain system securely stores and shares treatment data among healthcare providers and patients. The IoT sensor network monitors treatment parameters and provides real-time feedback to the blood treatment apparatus. The machine learning-based decision support system analyzes treatment data and provides personalized treatment recommendations. Additionally, the blood treatment apparatus incorporates a new material with enhanced biocompatibility and durability.

Novelty and Inventive Step

The new claims introduce a synergistic combination of technologies that creates a more powerful system, enabling personalized treatment recommendations, real-time feedback, and secure data management. The integration of AI, IoT, blockchain, and new materials with the blood treatment apparatus is novel and non-obvious compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the blood treatment apparatus with other technologies such as augmented reality, 5G networks, or advanced biomaterials. Variations of the inventive concept could include adapting the system for use in different medical applications or integrating it with existing healthcare infrastructure.

Potential Commercial Applications and Market

The intelligent blood treatment system has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, medical device development, and healthcare data management. The target market includes hospitals, clinics, and medical research institutions.

CPC Classifications

Section	Class	Group
A	A61	A61M1/1601
A	A61	A61M1/28
A	A61	A61M1/34
A	A61	A61M60/113
A	A61	A61M2205/3334

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically blood treatment apparatus design, involving complex medical equipment integration, control systems, and treatment optimization technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, control systems, data analytics, and medical technology integration, holding at least a Master's degree with 3-5 years of experience in medical device development

Obviousness Rationale

A PHOSITA would recognize that integrating advanced digital technologies like AI, IoT, and blockchain into existing blood treatment apparatus represents a predictable evolution of medical device design. The source patent's focus on precise control and treatment optimization naturally suggests opportunities for technological enhancement through data-driven approaches. The proposed variations represent logical extensions of existing medical device technological trends, utilizing well-established integration techniques.

Obvious Combinations & Variations

Source Patent Element

Blood treatment apparatus with flow control and treatment parameter management

PTD Variation

AI-powered predictive analytics module for treatment recommendation

Obviousness Reasoning

Predictable application of machine learning to optimize existing treatment control systems, representing a known technique for improving medical device performance through data analysis

Source Patent Element

Extracorporeal blood circuit with monitoring capabilities

PTD Variation

IoT-enabled sensor network providing real-time treatment parameter feedback

Obviousness Reasoning

Logical technological progression in medical device monitoring, using standard IoT integration techniques to enhance existing monitoring capabilities

Source Patent Element

Blood treatment apparatus with user input device for parameter adjustment

PTD Variation

Blockchain-based decentralized data storage for secure treatment data management

Obviousness Reasoning

Predictable application of emerging secure data management technologies to medical device information systems, representing a standard approach to improving data security and interoperability

Source Patent Element

Medical device constructed with standard biomedical materials

PTD Variation

New material with enhanced biocompatibility and durability

Obviousness Reasoning

Routine materials engineering approach to improving medical device performance, representing a standard design optimization strategy

Source Patent Element

Treatment control system with configurable parameters

PTD Variation

Machine learning-based decision support system for personalized treatment recommendations

Obviousness Reasoning

Predictable application of advanced analytics to existing treatment control methodologies, representing a known technique for enhancing medical device intelligence

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857711 and the technological context of medical device design, the proposed variations represent obvious extensions of existing blood treatment apparatus technologies. A person having ordinary skill in the art would find the integration of AI, IoT, blockchain, and advanced materials into blood treatment systems to be a predictable and logical technological progression, thereby rendering potential claims covering such variations obvious and unpatentable.

Original Patent Information

Patent Number	US 11,857,711
Title	Method for setting a control device or a closed-loop control device of a blood treatment apparatus, and devices
Assignee(s)	Fresenius Medical Care Deutschland GmbH